1 – 59 of 59
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
(
- Contribution to journal › Article
-
Mark
Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes : A secondary analysis of the POInT Study
(
- Contribution to journal › Article
-
Mark
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes
2024) In Diabetes Care(
- Contribution to journal › Article
-
Mark
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
2024) In Diabetologia(
- Contribution to journal › Article
-
Mark
Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk
2024) In The Journal of clinical endocrinology and metabolism(
- Contribution to journal › Article
-
Mark
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
2024) In Diabetologia(
- Contribution to journal › Article
-
Mark
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
2024) In Diabetologia(
- Contribution to journal › Article
-
Mark
Home capillary sampling and screening for type 1 diabetes, celiac disease, and autoimmune thyroid disease in a Swedish general pediatric population : the TRIAD study
(
- Contribution to journal › Article
-
Mark
Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic
2024) In Infection(
- Contribution to journal › Article
-
Mark
Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles
(
- Contribution to journal › Article
- 2023
-
Mark
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
(
- Contribution to journal › Article
-
Mark
Factors assessed in the first year of a longitudinal study predict subsequent study visit compliance : the TEDDY study
(
- Contribution to journal › Article
-
Mark
Refining the Definition of Stage 1 Type 1 Diabetes : An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
(
- Contribution to journal › Article
-
Mark
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
(
- Contribution to journal › Article
- 2022
-
Mark
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
(
- Contribution to journal › Article
-
Mark
Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies
(
- Contribution to journal › Article
-
Mark
Is staff consistency important to parents' satisfaction in a longitudinal study of children at risk for type 1 diabetes : the TEDDY study
(
- Contribution to journal › Article
-
Mark
Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease
(
- Contribution to journal › Article
-
Mark
Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA
(
- Contribution to journal › Article
-
Mark
Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children
(
- Contribution to journal › Article
-
Mark
Two-age islet-autoantibody screening for childhood type 1 diabetes : a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
(
- Contribution to journal › Article
-
Mark
Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study
(
- Contribution to journal › Article
-
Mark
The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study
(
- Contribution to journal › Article
-
Mark
Possible Relationship between the HLA-DRA1 Intron Haplotype of Three Single-Nucleotide Polymorphisms in Intron 1 of the HLA-DRA1 Gene and Autoantibodies in Children at Increased Genetic Risk for Autoimmune Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
(
- Contribution to journal › Article
- 2021
-
Mark
DPVis : Visual Analytics with Hidden Markov Models for Disease Progression Pathways
(
- Contribution to journal › Article
-
Mark
Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
First-appearing islet autoantibodies for type 1 diabetes in young children : maternal life events during pregnancy and the child's genetic risk
(
- Contribution to journal › Article
-
Mark
Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study : TEFA
(
- Contribution to journal › Article
-
Mark
Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies : Beyond a Simple Count
(
- Contribution to journal › Scientific review
-
Mark
Imputing Longitudinal Growth Data in International Pediatric Studies : Does CDC Reference Suffice?
(
- Contribution to journal › Article
-
Mark
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes : Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
(
- Contribution to journal › Article
-
Mark
Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts
(
- Contribution to journal › Article
- 2020
-
Mark
First European Case of Simultaneous Liver and Pancreas Transplantation as Treatment of Wolcott-Rallison Syndrome in a Small Child
(
- Contribution to journal › Article
-
Mark
Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies
(
- Contribution to journal › Article
-
Mark
Parental anxiety after 5 years of participation in a longitudinal study of children at high risk of type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
Predicting Type 1 Diabetes Onset using Novel Survival Analysis with Biomarker Ontology
(
- Contribution to journal › Article
- 2019
-
Mark
Effect of screening for type 1 diabetes on early metabolic control : the DiPiS study
(
- Contribution to journal › Article
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article
-
Mark
Metabolite-related dietary patterns and the development of islet autoimmunity
(
- Contribution to journal › Article
-
Mark
Practical management in Wolcott-Rallison syndrome with associated hypothyroidism, neutropenia, and recurrent liver failure : A case report
(
- Contribution to journal › Article
- 2018
-
Mark
Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes : A randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study
(
- Contribution to journal › Article
-
Mark
First trimester enterovirus IgM and beta cell autoantibodies in mothers to children affected by type 1 diabetes autoimmunity before 7 years of age
(
- Contribution to journal › Article
-
Mark
Influence of early-life parental severe life events on the risk of type 1 diabetes in children : the DiPiS study
(
- Contribution to journal › Article
- 2017
-
Mark
Preventing the Predictable. Type 1 diabetes in children: Risk factors and impact of participation in prospective follow-up
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Analgesic antipyretic use among young children in the TEDDY study : No association with islet autoimmunity
(
- Contribution to journal › Article
-
Mark
Psychological manifestations of celiac disease autoimmunity in young children
(
- Contribution to journal › Article
-
Mark
Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity?
(
- Contribution to journal › Article
- 2016
-
Mark
Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study
(
- Contribution to journal › Article
- 2015
-
Mark
Cord blood insulinoma-associated protein 2 autoantibodies are associated with increased risk of type 1 diabetes in the population-based Diabetes Prediction in Skane study
(
- Contribution to journal › Article
-
Mark
Immunology of β-Cell Destruction
2015) p.1047-1080(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Risk factors for type 1 diabetes in the Swedish prospective DiPiS study.
2015) Immunology of diabetes society(
- Contribution to conference › Poster
- 2014
-
Mark
Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up
(
- Contribution to journal › Article
-
Mark
Cord blood IA-2 autoantibodies increase the risk of type 1 diabetes in the population based DiPiS study cohort.
2014) ISPAD(
- Contribution to conference › Abstract